1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

18 Jul 2025
Admin
News Article

Corona Remedies acquires seven brands in cardiology & women’s healthcare from the pharmaceutical division of Bayer in India

About the acquisition

Corona Remedies has announced the acquisition of seven brands from the pharmaceutical division of Bayer in India.
Effective July 16, 2025, the acquisition encompasses several brands within the cardiology segment (Noklot) and the women’s healthcare portfolio (Fostine, Luprofact, Menodac, Ovidac, Spye, and Vageston) for the Indian market.
This strategic move strengthens Corona Remedies position in both the cardiology and women's healthcare segments. These products propose to offer growth under Corona Remedies stewardship going forward.

Corona enters into the anti-platelet market

Integrating these acquired brands into its portfolio marks Corona Remedies entry into the anti-platelet market, which is valued at Rs. 1,507 crores with an 8% growth rate.
Furthermore, it aims to strengthen Corona Remedies portfolio in women's healthcare by enhancing its presence in the gonadotrophin & progesterone hormone market, which stands at Rs. 1,862 crores as per MAT June’25.
This portfolio is primarily utilized for infertility treatment and pregnancy management.

Corona team’s work for promotion

Corona Remedies sales & marketing team and extensive distribution network will work to ensure that this newly acquired portfolio reaches patients across metro, semi-metro, urban, semi-urban, and rural areas.
The acquisition of these brands is expected to enhance Corona Remedies market presence and expand its portfolio.

The leagal advisor- GCV Life acted as the advisor for this transaction.

About the company: Corona Remedies Limited

Corona Remedies Limited, founded in 2004, is an India focused branded pharmaceutical formulation company engaged in developing, manufacturing & marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeutic areas.
Corona manufactures products for healthcare solutions as per international quality standards in its WHO-GMP/EU GMP-certified plant.
Corona has 2 DSIR-approved R&D centres with 80+ scientist teams working on new formulation development. Corona is a proud family of 4,000+ employees.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!